Aurobindo Pharma Limited

Water Mark Building, Plot No. 11
Survey no.9, Kondapur, Hitech City
Hyderabad 500084

Aurobindo Pharma Limited  -  - Company Summary

Manufacturers and Exporters of some of the most quality conscious Active Pharmaceutical Ingredients (bulk actives), intermediates, Peptides and speciality generic formulations.

Manufactures of semi synthetic penicillins and cephalosporins.

Manufacturer of Bulk Drugs, Intermediates & Formulations such as Antibiotic Penicillins, Antibiotic Cephalosporins, Anti - Microbials, Anti - Microbials - Quinolones, Macrolides, Sunfonamides, Antiprotozoals, Cardiovasculars, Anti Ashthmatics, Anti Fungals, Sterile - Parenterals, Fluroquinolo

Product Profile:

ANTI-DEPRESSANTS: Citalopram HBr, Bupropion HCl, Fluoxetine HCl,Gabapentin, Melitracin HCl, Mirtazapine, Paroxetine HCl, Risperidone, Sertraline HCl.

ANTI-CONVULSANTS- Leviteracetam,Topiramate.

HYPNOTICS & ANTI-PSYCHOTICS-Flupenthixol,Olanzapine,Zolpidem,Quetiapine,Zaleplon.

ANTI-HYPERTENSIVES-Benazepril, Fosinopril, Lisinopril, Perindopril, Quinapril, Ramipril, Trandolapril, Losartan Potassium.

BETA BLOCKERS- Bisoprolol Fumarate, Carvedilol.

THIAZIDE DIURETIC- Hydrochlorothiazide.

ANTI-THROMBOTIC - Clopidogrel bisulfate, Pentoxifylline.

STATINS- Atorvastatin Calcium, Fluvastatin, Simvastatin.

ANTI-DIABETICS- Gilbenclamide, Metformin HCL.

BPH-TREATMENT- Finasteride, Tamsulosin.

ANTI-EMETICS - Domperidone Base/Maleate, Ondansetron HCL.

ANTI-ULCERANTS - Lansoprazole Powder/Pellets, Omeprazole Powder/Pellets, Pantoprazole Sodium, Rabeprazole Sodium.

ANTI-RETROVIRALS- Abacavir, Didanosine, Efavirenz, Indinavir, Lamivudine, Lopinavir, Nelfinavir, Mesylate, Nevirapine, Ritonavir,

Saquinavir, Stavudine , Zidovudine .

ANTI-VIRALS - Ribavirin.

MACROLIDES- Azithromycin Monohydrate.

ANTI-FUNGALS - Fluconazole, Terbinafine HCl.

QUINOLONES- Ciprofloxacin HCL, Moxifloxacin

ANTI-HISTAMINES - Fexofenadine


ANTI-OSTEOPOROSIS -Alendronate Sodium




Associated Companies: APL Healthcare Limited

APL Research Centre Limited

Auronext Pharma Private Limited

Milpharm Limited

Novagen South Africa (JV)

APL Pharma Thai Limited (JV)

Aurobindo Ilac Sanayi Ve Ticaret Ltd STI

APL Swift services (Malta) Ltd

Agile Pharma (Malta) Ltd

Agile Malta Holdings

Auropharma Inc.

Aurohealthcare (Nigeria) Limited

Aurolife Pharma LLC

Aurosal Pharmaceuticals LLC (JV)APL Holdings (Jersey) Ltd

APL IP company Ltd

Laboratorios Aurobindo S.L.

ALL Pharma (Shangai) Trading Co. Ltd.

Pharmacin B.V.

Helix healthcare B.V.

General Information

  • Year established


  • Co.Registration No.


  • Legal form

    Limited Company

  • Corporate capital

    760,000,000 INR

  • Type of company


  • Fax

    +91 40 23741080, 23746833

  • Website




  • Standard Chartered Bank Standard Chartered Bank
  • Indian Bank Indian Bank
  • IDBI Bank Limited IDBI Bank Limited
  • Citibank N.A. Citibank N.A.
  • State Bank of Hyderabad State Bank of Hyderabad
  • State Bank of India State Bank of India
  • ICICI Bank ICICI Bank
  • HDFC Bank Ltd. HDFC Bank Ltd.
  • Andhra Bank Andhra Bank
  • Canara Bank Canara Bank


Area : Worldwide, Asia-Pacific, South America, Western Europe, Africa, North America, Central/East Europe
Country : China, Brazil, Japan, Netherlands, South Africa, Thailand, United Kingdom, United States, Russian Federation, Ethiopia, Ghana, Viet Nam, Hong Kong, Kenya, Tanzania



  • Type:

    ISO 9001


Aurobindo Pharma acquires Actavis operations in 7 European countries


Hyderabad: Aurobindo Pharma Ltd has completed the acquisition of certain commercial operations in Western Europe from Actavis Plc. In January this year, the Hyderabad-based Aurobindo Pharma had signed an agreement with Actavis to acquire its personnel, commercial infrastructure, products, marketing authorisations and dossier licence rights in seven European countries for €30 million.

Both companies had also inked a long-term commercial and supply arrangement.

“The acquisition will make Aurobindo one of the leading Indian pharmaceutical companies in Europe with a top 10 position in several key markets,’’ Muralidharan, Senior Vice-President of European operations for Aurobindo, said here on Tuesday.

Smooth transition

Aurobindo would work to combine the strength of both enterprises in these markets and to identify and maximise all opportunities.

“We will continue to collaborate with Actavis to ensure business continuity and a smooth transition. In parallel, we will work closely with the acquired management teams to achieve a rapid and successful integration,’’ he added. Aurobindo’s scrip gained 4.67 per cent on BSE on Tuesday to end at Rs. 534.70.

Disclaimer: Orignal source from IBEF


  • On site

    More than 5000 Employees

  • Company


  • 2015

    100 to 500 million INR

Financial ratios

  • Turnover


  • K. Ragunathan

    Director & Non-Executive Chairman

  • K. R.

    Director & Vice Chairman

  • N. G.

    Managing Director

  • M. R.


  • M. K.


  • M. M.


  • D. R.


  • A. S.


  • P. R.

    Non-Executive Director

  • P. R.

    Non-Executive Director

  • P. S.

    Purchase Head

Aurobindo Pharma Limited > Activities

  • Producer
  • Distributor
  • Service provider

You might also like:

Do you manage a company?

Register your company on Kompass for free to enhance your online presence. Contact potential prospects to help develop and build your business.

Register your company for free